Danaher

Yahoo Finance • 8 hours ago

Dental CAD-CAM Market Forecast and Company Analysis Report 2025-2029, with 3Shape, Align Technology, Carestream Dental, Dentsply Sirona, Jensen Dental, Schutz Dental, and Yenadent

Dublin, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The "Dental CAD-CAM Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The dental CAD-CAM market is projected to expand significantly, with an anticipated growth of USD 978.... Full story

Yahoo Finance • 3 days ago

Validea Detailed Fundamental Analysis - DHR

Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seek... Full story

Yahoo Finance • 4 days ago

Environmental Testing Products Company Evaluation Report 2025 | Agilent Technologies, Merck KGaA, and PerkinElmer Lead with Advanced Analytical and Life Science Solutions

Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Environmental Testing Products Company Evaluation Report" has been added to ResearchAndMarkets.com's offering. The Environmental Testing Companies Quadrant is a comprehensive industry an... Full story

Yahoo Finance • 5 days ago

DHR Factor-Based Stock Analysis

Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seek... Full story

Yahoo Finance • 5 days ago

Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi

Company Logo The Saudi Arabia Clinical Chemistry Analyzer Market is set to reach US$ 249.11 million by 2033, growing from US$ 170.98 million in 2024 at a 4.27% CAGR. Market growth is fueled by government healthcare investments under Visio... Full story

Yahoo Finance • 5 days ago

Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge

Company Logo The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investme... Full story

Yahoo Finance • 6 days ago

[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37... Full story

Yahoo Finance • 6 days ago

Wallace Weitz's Strategic Moves: Adobe Inc. Exit and Portfolio Adjustments

Insight into Weitz's Investment Philosophy and Recent Portfolio Changes Wallace Weitz (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. A... Full story

Yahoo Finance • 10 days ago

Al Gore's Generation Investment Management Reduces Amazon.com Inc by 3.8% in Q2 2025

Exploring the Strategic Moves of a Sustainability-Focused Investment Firm Introduction to Al Gore (Trades, Portfolio) and Generation Investment Management Warning! GuruFocus has detected 7 Warning Sign with MSFT. Al Gore (Trades, Portfo... Full story

Yahoo Finance • 13 days ago

Danaher Insiders Sold US$250m Of Shares Suggesting Hesitancy

The fact that multiple Danaher Corporation (NYSE:DHR) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When evaluating insider transactions, knowing whether insiders a... Full story

Yahoo Finance • 14 days ago

Noteworthy ETF Outflows: XLV, PFE, SYK, DHR

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $1.2 billion doll... Full story

Yahoo Finance • 14 days ago

AMGN Named A Top Socially Responsible Dividend Stock

Amgen Inc (Symbol: AMGN) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 3.3% yield, as well as being recognized by prominen... Full story

Yahoo Finance • 19 days ago

Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Drug Abuse Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. Drug Abuse Testing Market is... Full story

Yahoo Finance • 20 days ago

Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report

ARLINGTON, Va., July 29, 2025 /PRNewswire/ -- A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market surged past $36 billion in 2024, with projections pointing to continued growth through 2029... Full story

Yahoo Finance • 21 days ago

Bernstein upgrades Sartorius to “outperform” on margin recovery, pharma demand

Investing.com -- Sartorius AG (F:SATG) has been upgraded to “outperform” from “market perform” by analysts at Bernstein, citing a renewed margin expansion trajectory and signs of an upturn in pharmaceutical capital spending, in a note date... Full story

Yahoo Finance • 26 days ago

Thermo Fisher beats quarterly estimates on resilient demand for its tools and services

(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5... Full story

Yahoo Finance • 27 days ago

Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline

Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the consensus of $5.84 billion. The life science giant reported adjusted earnings of $1.80 per share, beating the cons... Full story

Yahoo Finance • 27 days ago

Danaher raises full-year EPS guidance to $7.70-$7.80 amid robust bioprocessing growth and portfolio resilience

Earnings Call Insights: Danaher Corporation (DHR) Q2 2025 MANAGEMENT VIEW * Rainer M. Blair, President and CEO, announced a CFO succession plan, stating that "Matt Gugino, the current group CFO of our Life Sciences Innovation Group and... Full story

Yahoo Finance • 27 days ago

Danaher slips despite Q2 beat as Life Sciences unit underperforms

[Rolled newspaper with the headline Quarterly Results] Zerbor/iStock via Getty Images Danaher Corporation (NYSE:DHR [https://seekingalpha.com/symbol/DHR]) traded ~4% lower in the premarket on Tuesday after the company’s Q2 2025 financials... Full story

Yahoo Finance • 27 days ago

Earnings Snapshot: Danaher surpasses Q2 estimates; raises FY25 Adj. EPS outlook

[Seeking Alpha] Seeking Alpha (Seeking Alpha)   *Other Operating Data Consensus Source: Bloomberg MORE ON DANAHER * Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside [https://seekingalpha.com/article... Full story